Natalizumab induced cutaneous sarcoidosis-like reaction.
Journal
Journal of neuroimmunology
ISSN: 1872-8421
Titre abrégé: J Neuroimmunol
Pays: Netherlands
ID NLM: 8109498
Informations de publication
Date de publication:
15 08 2019
15 08 2019
Historique:
received:
21
03
2019
revised:
27
04
2019
accepted:
29
04
2019
pubmed:
21
5
2019
medline:
24
3
2020
entrez:
21
5
2019
Statut:
ppublish
Résumé
We present a case of a drug-induced sarcoidosis -like reaction (DISR) occurring following initiation of Natalizumab for multiple sclerosis. The reaction was purely cutaneous, and disappeared following drug withdrawal. We highlight this case to the practicing neurologists, with warning to be wary of a new rash on immunomodulatory therapies.
Identifiants
pubmed: 31108403
pii: S0165-5728(19)30136-5
doi: 10.1016/j.jneuroim.2019.04.015
pii:
doi:
Substances chimiques
Immunologic Factors
0
Natalizumab
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
476955Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.